|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00660 WAI CHUN BIOTEC
Nominal 
0.260 0.000 (0.000%) | 2025/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/06 HKD(K$) | |
| Turnover | 352,150 | 118.651% | 161,056 | 190,330 | 405,080 | 287,873 |
| Cost of Sales | (316,494) | 126.187% | (139,926) | (173,535) | (378,389) | (259,129) |
| Gross Profit | 35,656 | 68.746% | 21,130 | 16,795 | 26,691 | 28,744 |
| 2025/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/06 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (3,321) | -70.354% | (11,202) | (2,845) | (3,779) | 2,863 | |
| Taxation | (2,425) | 30.940% | (1,852) | (1,185) | (1,529) | (1,072) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (193) | -68.204% | (607) | (2,704) | (2,523) | (6,265) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (5,939) | -56.526% | (13,661) | (6,734) | (7,831) | (4,474) | |
| 2025/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/06 HKD(K$) | |
| Net Finance Costs / (Income) | 5,045 | -51.364% | 10,373 | 8,829 | 8,424 | 6,284 |
| Depreciation & Amortisation | 2,626 | -67.783% | 8,151 | 5,650 | 5,267 | 4,981 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/12 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/12 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/06 | |
| EPS (cts) | -3.330 | -58.218% | -7.970 | -3.930 | -4.570 | -2.700 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | (0.357) | -- | (0.543) | (0.227) | (0.280) | (0.246328) |
| Remarks: | Real time quote last updated: 05/03/2026 17:04 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -5,939 |
| %Change | -56.526% |
| EPS / (LPS) | HKD -0.033 |
| NBV Per Share ($) | HKD -0.357 |